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Annotation Guide for Determining 
Methods Keystone Citations 
 
Tasnia Haque, Tiffany Lam, Muhammad Rahmen, Karla Gonzales-Cruz, Yuanxi Fu 
 
This annotation guide describes the procedures for determining whether a citation is a methods 
keystone citation for a paper. It was developed by a team of five annotators with academic 
background and/or research experience in the biomedical domain in Summer 2021 as a part of 
American Physician Scientists Associations’ Undergraduate Virtual Summer Research Program 
(VSRP). The annotation scheme is shown in Figure 1.  
 
 
Figure 1. Annotation Scheme 
 
1. Glossary 
Citation string: the text of a citation. Example: 
(Yasuda and Mayford, 2006)  
Citation context: the text surrounding a citation string. Example: 
We took advantage of a mouse line in which expression of a tet transactivator 
transgene is under control of the neuropsin gene promoter (Yasuda and 
Mayford, 2006). [PMID 22365544] 
(Yasuda and Mayford, 2006) is the citation string, and We took advantage of a mouse 
line in which expression of a tet transactivator transgene is under control 
of the neuropsin gene promoter is the citation context. 
Keystone framework [2]: A theoretical framework that guides literature users through a formal 
process to trace the impact of a citation. The keystone framework combines two approaches: 
1. Argument-based modeling, which represents a scientific paper based on its argument 
structure and  
2. Citation context analysis, here to understand how a citation fits into the argument 
structure. 
Citing paper: a paper citing another paper. 
Cited paper: a paper being cited by another paper.  
Keystone citations: if the unreliability of the statement made in a citation context would threaten 
the argument for a main finding of a paper, we call the citation context a “keystone citation 
context” and the citation associated with the citation context a “keystone citation.”  
Methods keystone citations: keystone citations that support research methods and materials.  
NOTE: Their role can (often) be determined by the citation context only, without understanding 
the entire paper, which makes them good candidates for automated extraction. 
We need to clarify three concepts immediately, methods, materials, and support. 
Method: The way of doing research, a reusable procedure designed to answer research questions 
and produce research findings. Computer programs and computer scripts are instantiations of 
methods, and we will group them into methods. 
Material: physical resources used in methods, such as reagents, plasmids, animal models, 
datasets. Computer programs and computer scripts are NOT materials. 
Support: “Support” has two meanings here. The first meaning is “attribution.” In this case, a 
citation is “stuck” next or close to a method or material. The purpose is to show where the 
method or material comes from. The citation could refer to a paper describing the method or the 
material. I personally believe such usage should be replaced by something like the research 
resource identifications 1, but using a paper seems to be still a common convention of citing 
methods or materials.  
 
1 https://scicrunch.org/resources 
Second, we may find close to the citation an explicit statement about a scientific fact, where that 
statement justifies the decisions made in the design of the methods. In such case, “support” 
means that the citation provides evidence that the given statement is true.  
Micropublication model [1]: a machine-readable representation of publications in the 
biomedical domain. We use it to model biomedical publications and to find elements supporting 
a paper’s argument. In particular, “scientific evidence” consists of “Data” and “Methods” (= 
materials and methods). 
Methods paper: papers whose primary goal is to report a method/methods. We also consider 
reviews of methods, tutorials of methods (e.g., PMID 22214542), and comparative studies of 
methods (e.g. PMID 24681694) as “methods papers.” 
Non-methods paper: papers whose primary goal is not to report a method/methods, (e.g., to 
report scientific discoveries, to summarize the status-quo of a research field)   
 
2. The Structure of the Annotation Sheet 
For this annotation task, you will receive a worksheet containing the following columns: 
ID: unique identifier for the sentence 
CITED_PMID: PMID of the cited article 
CITING_PMID: PMID of the citing article 
CITATION_CONTEXT: the citation context that needs to be annotated 
ANNOTATION: three options, IS_METHODS_KEYSTONE, NOT_METHODS_KEYSTONE, or 
UNCERTAIN 
EXPANDED_CITATION_CONTEXT: the citation context we provide you is the sentence that 
contains the citation string (S[0]). However, you may need the sentence before (S[-1]) or the 
sentence after (S[1]) to make your decision, or even further, S[ -N] or S[N]. Record the extra 
citation context you used in this cell, and make sure the text span is continuous. For example, if 
you used S[2], make sure you include S[1] in this field as well.  Copy the WHOLE TEXT SPAN in the 
field, including what is in the “CITATION CONTEXT” field. We need this expanded citation context 
in case we want to train classifiers that take more sentences than just the sentence containing 
the citation string. Also, if you read more and FOUND that the citation IS a keystone citation, 
RECORD the expanded citation context. If you read more and FOUND that the citation is still NOT 
a keystone citation, you DON’T need to record the expanded citation context. In other word, only 
if you find a citation IS a keystone citation and you made the decision based on text beyond the 
sentence that contains the citation string, you will need to record the expanded citation context. 
IS_CITED_METHODS_PAPER: is the cited paper a methods paper. IS_METHODS_PAPER, 
NOT_METHODS_PAPER, or UNCERTAIN  
SUBTYPE: write down the subtype.  
NOTES: leave your notes here, anything you want us to know. 
 
3. Step-by-step Guide 
The basic idea of a methods keystone citation is that the citation supports research methods or 
materials.  
Step 1: Read the content in the ”CITATION_CONTEXT” column. Identify the statement that is 
supported by the citation. Notice that there is sometimes no such explicit statement. See the 
examples below. 
Case 1: Citation context not containing an explicit statement supported by the citation. 
“Following the protocol of Hoye and co-workers,17 32 structures 
(corresponding to all possible diastereomers at nitrogen 15 and carbons 12, 
13, 14 and 17 of 2,18Fig. 2) were generated.” [PMID 28959410] 
There is no explicit statement about a scientific fact near the citation string ’17.’ Reference 17 
does not support a statement, and it is an appositive of “the protocol of Hoye and co-workers.” 
Still, reference 17 is where the protocol come from, and it fits our definition o f “support” (see 
section 1). Reference 17 is still a methods keystone citation. 
Case 2: Citation context containing a statement supported by the citation. 
Immunohistochemistry using the 5A6 antibody (courtesy of Dr.G.V. Johnson, 
University of Rochester), a monoclonal antibody raised against the longest 
form of recombinant human tau which recognizes an epitope between amino acids 
19 and 46 (Johnson et al., 1997), confirmed strong expression of tau protein 
in superficial layers of the MEC and parasubiculum in rTgTauEC mice at 3 
months of age compared to a control brain (Figure 1D).[PMID 22365544]] 
Here, the text in bold is a statement about a property of 5A6. Supposedly, the article (Johnson et 
al., 1997)  provides evidence that this statement is true.  
However, there are gray areas between case 1 and case 2. For example: 
“We utilized the well-characterized rTG4510 mouse line as a model of tauopathy 
(Jackson Lab, Bar Harbor, ME, USA) [63].[PMID 28959410]” 
Do we call “as a model of tauopathy” an explicit statement? It’s hard. On one hand, it does 
not have a proper noun and verb, hardly a statement. On the other hand, it says something, that  
rTG4510 mouse line is a model of tauopathy. However, you only need to pay attention to the 
existence to such distinctions. We have designed the annotation scheme so that the gray areas 
cases we found so far won’t affect your classifications, i.e., you won’t get a different classification 
result because you think the example above is case 1 or case 2.   
Step 2: Make an initial guess about whether or not it is a methods keystone citation. More 
specifically: 
1. if there is NO explicit statement, and a citation string is stuck next or close to a method 
or material USED in a paper to show where the method or material comes from à this 
citation is a methods keystone citation. 
2. If there IS an explicit statement with the citation, and the statement is about the method 
or the material USED in a paper à this citation is a methods keystone citation. 
3. If there IS an explicit statement with the citation, and the statement helps to justify 
certain decisions made in the design of the methods used in this paper à this citation is a 
methods keystone citation. 
Make an initial guess but don’t rush to the conclusion. Go to step 3.  
Step 3: Go to PubMed2 and use CITING_PMID to find the full text of the citing article. Locate 
where the citation context is and read the text surrounding it.  
1. If you think the citation is a methods keystone citation, verify that.  
2. if you don’t think the citation is a methods keystone citation, also verify that. Sometimes, 
a citation may seem to have nothing to do with the method or the material used in the 
paper, but if you look in the vicinity of the sentence, you may find otherwise. For examples, 
see section 4.1.3, 4.1.4 and 6.1.  
Step 4: Do three things: 
1. In the “ANNOTATION” column, note down your decision.  
2. If you used extra text, record the expanded citation context in the 
“EXPANDED_CITATION_CONTEXT” field. Again, you add expanded citation context only if 
(1) the citation is a methods keystone citation and (2) you cannot tell it’s a methods 
keystone citation without including the extra text. 
3. Record anything you want us to know in “NOTES.” 
Step 5: In the last step, use the CITED_PMID to pull out the abstract of the cited paper. Determine 
whether it is a methods paper. Record your decision in “IS_CITED_METHODS_PAPER.” 
4. Examples 
Let’s look at some examples together. 
 
2 The website of PubMed: https://pubmed.ncbi.nlm.nih.gov/. Another website you may need to know is the 
PubMed central: https://www.ncbi.nlm.nih.gov/pmc/. The associated identifiers are PMCID.  
4.1 Examples where the cited paper IS a methods keystone citation 
4.1.1 Used the method 
Example 1: without an explicit statement; the citation is an attribution to the paper that describes 
the method 
“Following the protocol of Hoye and co-workers,17 32 structures (corresponding 
to all possible diastereomers at nitrogen 15 and carbons 12, 13, 14 and 17 of 
2,18Fig. 2) were generated.” [PMID 28959410] 
Here, 17 s the citation string. We do not see a statement about scientific facts regarding this 
citation. “The protocol of Hoye and co-workers” is an appositive of reference 17. Still, reference 
17 is where the protocol come from, and it fits our definition of “support ,” because it’s an 
attribution(i.e., where the method came from). Therefore, reference 17 is a methods keystone 
citation.  




CITATION_CONTEXT Following the protocol of Hoye and co-workers,17 32 
structures (corresponding to all possible diastereomers at 





SUBTYPE Used the method 
NOTES  
 
Example 2: with an explicit statement, and the statement is about the method used in the paper) 
– haven’t found one yet. Fill in later 
 
4.1.2 Used the material 
Example 1: without an explicit statement; the citation is an attribution of a material used 
We utilized the well-characterized rTG4510 mouse line as a model of tauopathy 
(Jackson Lab, Bar Harbor, ME, USA) [63].[PMID: 29562600] 
In this example, the citation context does not contain a statement about a scientific fact 
supported by the citation. Reference 63 is “stuck” close to “well-characterized rTG4510 mouse 
line,” likely as an attribution. Because the experiment used the rTG4510 mouse line, reference 





CITATION_CONTEXT We utilized the well-characterized rTG4510 mouse line as 





SUBTYPE Used the material 
NOTES  
 
Example 2: with an explicit statement, and the statement is about material used in the paper 
Immunohistochemistry using the 5A6 antibody (courtesy of Dr.G.V. Johnson, 
University of Rochester), a monoclonal antibody raised against the longest form 
of recombinant human tau which recognizes an epitope between amino acids 19 and 
46 (Johnson et al., 1997), confirmed strong expression of tau protein in 
superficial layers of the MEC and parasubiculum in rTgTauEC mice at 3 months of 
age compared to a control brain (Figure 1D). [PMID:22365544] 
Here, (Johnson et al., 1997) is with a statement “a monoclonal antibody raised against 
the longest form of recombinant human tau which recognizes an epitope between 
amino acids 19 and 46.”  And the statement is about a material used in the paper, the antibody 






CITATION_CONTEXT Immunohistochemistry using the 5A6 antibody (courtesy 
of Dr.G.V. Johnson, University of Rochester), a monoclonal 
antibody raised against the longest form of recombinant 
human tau which recognizes an epitope between amino 
acids 19 and 46 (Johnson et al., 1997), confirmed strong 
expression of tau protein in superficial layers of the MEC 
and parasubiculum in rTgTauEC mice at 3 months of age 




SUBTYPE Used the material  
NOTES  
 
4.1.3 Used the output of a paper in methods 
If a citing paper explicitly stated that it used the output of a paper (e.g. data produced, code 
produced) in its methods, the cited paper is a methods keystone citation.  
Example: 
For the level of theory used herein [B3LYP/6-311+G(2d,p)//M06-2X/6-31+G(d,p)] 
the following values have been calculated by Willoughby et al.:16 for 1H: 
intercept = 31.9477, slope = –1.0767; for 13C: intercept = 181.2412, slope = 
–1.0522. 
Here, 16 is the citation string, which refer to paper 16 in the bibliography list: P. H. Willoughby, 
M. J. Jansma and T. R. Hoye, Nat. Protocols, 2014, 9, 643– 660. The citation context tells us that 
reference 16 provided a set of values (e.g., intercept, slope). However, we cannot determine 
whether reference 16 is a keystone citation, because we don’t know whether the values 
provided by reference 16 are used in the paper as a part of the method. So we go back to the 
full paper3. This paper is not open access, so you will need to use your university’s resources to 
view the full text. If your university does have access to the full text, note that in the “NOTES” 
section. 
In the full text, we find this sentence is located in the “Computational Methods” section, a good 
sign! Then we find the sentence before this one (S[-1]) 
In the present study, we used generic-scaling factors obtained from large 
datasets [i.e. obtained from linear regression analysis of a plot of calculated 
isotropic magnetic shielding tensors (σiso) against experimental chemical 
shifts (δexpt) of a large series of compounds]; these scaling/referencing 
factors are specific of the level of theory used. [DOI 10.1002/ejoc.20190136] 
From S[-1], we learnt that the authors used something (“generic-scaling factors obtained from 
large datasets”) in the present study. And it also says that the scaling factor should be “specific 
of the level of theory used.” Notice in S[0], it says that “For the level of theory used herein … 
the following values have been calculated by Willoughby et al.:16” Now we are certain that 
those values from reference 16 have been used in the method of the citing paper, but we need 
a wider range of text to determine that. The annotation entry would look like the following. In 
particular. Because this is a methods keystone citation, and we cannot tell that without the 
extra text we need to include both the citation context and the sentence before it in the 
“EXPANDED_CITATION_CONTEXT” field.  
 
3 https://chemistry-europe.onlinelibrary.wiley.com/doi/full/10.1002/ejoc.201901363 
NOTE: There needs to be a clear indication that the material/data or others is the output of the 
citing paper. For example, here, it says that “the following values have been calculated by 






CITATION_CONTEXT For the level of theory used herein [B3LYP/6-
311+G(2d,p)//M06-2X/6-31+G(d,p)] the following values 
have been calculated by Willoughby et al.:16 for 1H: 
intercept = 31.9477, slope = –1.0767; for 13C: intercept = 
181.2412, slope = –1.0522. 
ANNOTATION IS_METHODS_KEYSTONE 
EXPANDED_CITATION_CONTEXT In the present study, we used generic-scaling factors 
obtained from large datasets [i.e. obtained from linear 
regression analysis of a plot of calculated isotropic 
magnetic shielding tensors (σiso) against experimental 
chemical shifts (δexpt) of a large series of compounds]; 
these scaling/referencing factors are specific of the level of 
theory used. For the level of theory used herein [B3LYP/6-
311+G(2d,p)//M06-2X/6-31+G(d,p)] the following values 
have been calculated by Willoughby et al.:16 for 1H: 
intercept = 31.9477, slope = –1.0767; for 13C: intercept = 
181.2412, slope = –1.0522. 
IS_CITED_METHODS_PAPER IS_METHODS_PAPER 
SUBTYPE Used the output of a paper in methods 
NOTES  
 
4.1.4 Justify decisions made in the design of the methods 
Research methods are designed to answer research questions. The design decisions are often 
made based on facts. A general observation is that a non-methods paper provided a finding, and 
the finding (a scientific statement) was used to justify actions taken in the methods in the citing 
paper.   
What do I mean by “justify decisions?”  
Example 1 
 
4 This paper doesn’t have a PMID, we use DOI (Digital Object Identifier) instead. 
In AD, early hallmarks include the loss of synapses, and comparison of AD 
patients to age-matched control individuals showed that the density of synapses 
correlated strongly with cognitive impairment, suggesting that loss of 
connections is associated with the progression of the disease (DeKosky and 
Scheff, 1990; Scheff and Price, 2006; Terry et al., 1991). Therefore, we 
assessed two synaptic markers in the perforant pathway terminal zone of rTgTauEC 
mice: synapsin-I, a marker of synaptic vesicles, and PSD-95, a postsynaptic 
marker that has been reported to decrease early in neurodegeneration (Zhao et 
al., 2006). [PMID 22365544] 
The cluster citation (DeKosky and Scheff, 1990; Scheff and Price, 2006; Terry et al., 1991) 
supported the statement that there is an association between loss of synapses to the 
progression of the disease. This statement provides the premise for the experimental design: 
the use of synaptic markers to measure neurodegeneration. On the flip side, if it turned out 
that loss of synapses is NOT associated with the progression of the diseases, the scientists 
shouldn’t use synaptic biomarkers for this study at all.  Also notice, we need expanded citation 
context to discover the fact that (DeKosky and Scheff, 1990) is a keystone citation. 




CITATION_CONTEXT In AD, early hallmarks include the loss of synapses, and 
comparison of AD patients to age-matched control 
individuals showed that the density of synapses correlated 
strongly with cognitive impairment, suggesting that loss of 
connections is associated with the progression of the 
disease (DeKosky and Scheff, 1990; Scheff and Price, 2006; 
Terry et al., 1991). 
ANNOTATION IS_METHODS_KEYSTONE 
EXPANDED_CITATION_CONTEXT In AD, early hallmarks include the loss of synapses, and 
comparison of AD patients to age-matched control 
individuals showed that the density of synapses correlated 
strongly with cognitive impairment, suggesting that loss of 
connections is associated with the progression of the 
disease (DeKosky and Scheff, 1990; Scheff and Price, 2006; 
Terry et al., 1991). Therefore, we assessed two synaptic 
markers in the perforant pathway terminal zone of 
rTgTauEC mice: synapsin-I, a marker of synaptic vesicles, 
and PSD-95, a postsynaptic marker that has been reported 
to decrease early in neurodegeneration (Zhao et al., 2006). 
IS_CITED_METHODS_PAPER NOT_METHODS_PAPER 




For studies investigating presynaptic bouton density, digital images from lamina 
III of the midfrontal gyrus were obtained, because this particular laminar area 
has been associated with AD-related synaptic changes in previous studies (Paula-
Barbosa et al., 1986; DeKosky and Scheff, 1990). [PMID: 17913914] 
In this example, researchers decided to obtain “digital image from lamina III of the midfrontal 
gyrus” because “this particular laminar area has been associated with AD-related synaptic 
changes in previous studies,” which is supported by citations (Paula-Barbosa et al., 1986; DeKosky 
and Scheff, 1990). This is another example where citations “Justify decisions made in the design 




CITATION_CONTEXT For studies investigating presynaptic bouton density, 
digital images from lamina III of the midfrontal gyrus were 
obtained, because this particular laminar area has been 
associated with AD-related synaptic changes in previous 
studies (Paula-Barbosa et al., 1986; DeKosky and Scheff, 
1990). 
ANNOTATION IS_METHODS_KEYSTONE 
EXPANDED_CITATION_CONTEXT For studies investigating presynaptic bouton density, 
digital images from lamina III of the midfrontal gyrus were 
obtained, because this particular laminar area has been 
associated with AD-related synaptic changes in previous 
studies (Paula-Barbosa et al., 1986; DeKosky and Scheff, 
1990). 
IS_CITED_METHODS_PAPER NOT_METHODS_PAPER 
SUBTYPE Justify decisions made in the design of the methods 
NOTES  
 
4.2 Example citation context where a cited paper is NOT a methods keystone citation 
4.2.1 Cited as background information 
Example 
Simultaneously, advances in calculation of NMR properties from first principles 
(ab initio) made considerable progress with the introduction of Density 
Functional Theory; today’s DFT-based methods can be quite accurate [3] and 
reasonably turnkey, if time-consuming, protocols have been developed for their 
application [4]. [PMID 31388784] 
This citation context contains two citation strings, [3] and [4]. What we want to analyze here is 
whether reference 4 is a methods keystone citation. 
Reference 4: “Willoughby PH, Jansma MJ, Hoye TR. A guide to small-molecule structure 
assignment through computation of (1H and 13C) NMR chemical shifts. Nat Protoc. 
2014;9(3):643–60. doi: 10.1038/nprot.2014.042.”  
The citation context says that “reasonably turnkey, if time-consuming, protocols have been 
developed for their application” about reference 4, which does not imply that reference 4 has 
been used in this citing article. Our instinct should be “NOT_KEYSTONE.” If we go back to the 
paper 5 , we find that the citation appeared in introduction and only provides background 
information. Therefore, we decide that reference 4 is “NOT_KEYSTONE.” However, be very 
careful with this subtypesub-category. We’ve encountered citation context that read like a 
background information but in fact contain methods keystone citations (see section 4.1.3, 4.1.4 





CITATION_CONTEXT Simultaneously, advances in calculation of NMR properties 
from first principles (ab initio) made considerable progress 
with the introduction of Density Functional Theory; 
today’s DFT-based methods can be quite accurate [3] and 
reasonably turnkey, if time-consuming, protocols have 




SUBTYPE Cited as background information 
NOTES  
 
4.2.2 Citing/Cited agree 
A citing paper may use another paper whose findings agree with it to reinforce its argument. 
For example:  
The predicted MAE values for the 1H NMR chemical shifts indicate that our 
fits (∼0.10 ppm) are in line with the errors obtained for much smaller 
molecular systems.40,41 [PMID 30474677] 
In this example, references 40 and 41 were used to match what authors found in the citing 
paper. They are not methods keystone citations, because they are not used to support 
methods. However, if reference 40 and 41 were invalidated, they may cast doubts on the 
 
5 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684566/ 
validity of the citing paper, as the citing paper’s findings “are in line” with invalidated papers. 





CITATION_CONTEXT The predicted MAE values for the 1H NMR chemical shifts 
indicate that our fits (∼0.10 ppm) are in line with the 




SUBTYPE Citing/cited agree 
NOTES  
 
4.2.3 Citing/Cited disagree 
A citing paper may also disagree with a reference it cites. For example,  
Taking a Boltzmann average of NMR parameters computed for individual 
conformers, as suggested for example by Willoughby and co-workers,10 is 
necessary but unfortunately insufficient to model real systems. [PMID 
28906074] 
Apparently, the authors of this paper disagree with reference 10. As reference 10 is not used to 
support research methods and materials, it is not a methods keystone citation. Moreover, if 
reference 10 turned out to be invalidated, that fact wouldn’t hurt this citing paper at all. We 





CITATION_CONTEXT Taking a Boltzmann average of NMR parameters 
computed for individual conformers, as suggested for 
example by Willoughby and co-workers,10 is necessary but 




SUBTYPE Citing/cited disagree 
NOTES  
 
4.2.4 Used in knowledge synthesis 
A paper’s findings (claims, scientific statement) can be used in a citing paper for knowledge 
synthesis to generate new knowledge. If such new knowledge are main findings, the citation 
will qualify as a keystone citation. However, they are still NOT a methods keystone citation, 
because they are not used to support methods. 
Example 
This different localization pattern might be pathologically significant given 
that missorting of p-tau to neurites and synaptic loss in the frontal cortex 
are early hallmarks of AD and are highly correlated with cognitive loss in AD 
patients (Davies et al., 1987; DeKosky and Scheff, 1990; Scheff et al., 1990). 
[PMID: 22464332] 
Here, some new knowledge is generated through old knowledge. The new knowledge is that 
“This different localization pattern might be pathologically significant”, and the old knowledge is 
that: “missorting of p-tau to neurites and synaptic loss in the frontal cortex are early hallmarks 
of AD and are highly correlated with cognitive loss in AD patients,” supported by citations. 
However, the citation (DeKosky and Scheff, 1990) is NOT a methods keystone citation, because 
this citation does not support methods or materials. Moreover, since with only this sentence, we 
cannot know whether the new knowledge is a “main finding”, we cannot determine whether the 
citation is a keystone citation. 
Also, for a citation context to qualify as this subtype, knowledge synthesis must be explicit in a 
single sentence, like shown in the example. The reason we made the limitation is that, given 
enough text spans, anything is the paper is a step in the knowledge synthesis towards the 
conclusion.  




CITATION_CONTEXT This different localization pattern might be pathologically 
significant given that missorting of p-tau to neurites and 
synaptic loss in the frontal cortex are early hallmarks of AD 
and are highly correlated with cognitive loss in AD patients 





SUBTYPE Used in knowledge synthesis 
NOTES  
 
4.2.5 Qualifying methods 
Interesting, sometimes papers, especially methods papers, can be cited to qualify the methods 
authors used in a paper (i.e., pointing out the weakness of the methods used). Such citations 
won’t be keystone citations, because if the cited paper is wrong, either there is no impact on 
the citing paper or, even better, the weakness may no longer exist anymore. See the below 
examples. 
We used a 2-stage modeling approach; therefore, our estimates in the second 
stage may have been biased with 95% CIs that were too narrow [57]. (PMID 28490512) 
Supposedly, reference 57 provided evidence that the authors ’ estimate in the second stage may 
have been biased, a weakness of the authors’ method.   
Another example: 
However, the Telometric program we used [38, 48] has been criticized for 
yielding biased results [26, 28, 49].(PMID 26789258) 
Again, the papers cited were to criticize the method used in the paper.  
Note: This category may confuse with b3: Citing/Cited disagree. In b3, we are talking about 
findings, and here, it is about criticism of methods.   
 
5. A summary of subtypes 
Is methods keystone citation Not methods keystone citation 
a1. Used the method 
a2. Used the material  
a3. Used output of a paper in methods.  
a4. Justify decisions made in the design of 
the methods.  
 
b1. Cited as background information 
b2. Citing/Cited agree 
b3. Citing/Cited disagree 
b4. Used in knowledge synthesis 
b5. Qualifying method 
 
 
NOTE: for a citation context to be counted as a3 subtype, there must be an explicit statement 
that the thing used in the methods of the citing paper IS output of the cited paper.  
NOTE: for subtype b4, knowledge synthesis must be explicit in ONE sentence. The reason is that 
given long enough text spans, anything talked about in the paper is a part of the knowledge 
synthesis. 
NOTE: be very careful with b1: Many citation contexts containing methods keystone citations 
read like background information. Before you assign this category, make sure you’ve read the 
sentences around it, and made sure it’s not a4 type.  
6. Tricky cases 
6.1. Detached citation 
Definition: Materials/Methods were used but without citation where the usage was expressed.  
Example: 
The phospho-independent Tau-12 and 5A6 monoclonal antibodies and CR Polyclonal 
antibody (Fig. 1A, Table 1) were selected for investigation of early N-terminal 
changes because of their overlapping epitopes spanning the extreme N terminus 
of tau. The contribution of tyrosine phosphorylation of tau at Y18 was assessed 
with the phosphotyrosine-specific 9G3-pY18 antibody, raised against a 
phosphorylated peptide corresponding to amino acids 12-24 of tau (Lee et al., 
2004). Tau-12 (previously attributed to residues 9-18) and 5A6 (residues 19-46) 
were both raised against purified recombinant human tau (Johnson et al., 1997; 
Ghoshal et al., 2002).[PMID: 15356202] 
In this example, we know that the material 5A6 is used in the experiment from the first 
sentence. However, two sentences away, we get a citation for 5A6. 
7. Reconciliation principles 
1. A third annotator will carry out the reconciliation process independently  
2. This annotator will only reconcile items that previous two annotators disagree.  
3. Only “ANNOTATION”, “SUBTYPE”, and “IS_METHODS_PAPER” columns will be reconciled. 
Three annotators’ entries in “EXPANDED_CITATION_CONTEXT” and “NOTES” column will be 
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Appendix: Methods and Non-methods papers 
28330228 tricky cases 
 
Appendix: Other documentations 
1. Muhammad pointed out that the old a2 “used output of a paper in methods” and a3 
“support that material X has property Y” have overlaps. Because a paper can use the output of 
a citing paper and the reason to use that output is because “material X has property Y.” To 
remove such confusion, I narrowed the scope of a2 down to “Used output of a methods paper 
in methods.”  
2. Based on Tiffany’s input, I was thinking about mirroring 4.1.1 “Support that material X has 
property Y” and generalizing 4.1.2 to “Support that method X can study phenomenon Y.” But I 
decided against making this move now,  because the expression is squishier than the current 
one. Given my discussion with them, I feel it’s safer with the students to be very specific about 
what they are looking for. If we discover more subtypes, we will eventually merge them to 
“Support method X can …… ” That’s why I left a note saying “this may be a subtype of methods 
authorize claims.” 
3. In the future, a1 and a2 can be combined to one sub-category. But I decided to separate 
them now. 
4. I combined a3 to a5 because I realize the subtypes start to get out of control, after I 
discovered another subtype “Support that anatomy region X has property Y”. I  think it’s time to 
use “Justify actions taken in methods” as an over-arching subtype.  
5. subjective evaluations: 
The predictions of chemical shift values by quantum chemical methods have 
provided valuable insights into natural product structures, including guiding 
the choice of diastereomer for structure confirmation by total synthesis [ <cite 
data-doi="10.1021/cr200106v"> 8 </cite> , <cite data-doi="10.1039/c3np70028c"> 
9 </cite> , <cite data-doi="10.1038/nprot.2014.042"> 10 </cite> ]. 
Computational studies on DFT level to date are the most attractive for 
investigation of reactions thermodynamic parameters, conformational analysis 
and prediction of products spectral properties <cite data-
doi="10.1038/nprot.2014.042">[7]</cite>. 
Would this citation context qualify the WH protocol as a keystone citation? 
MR: no indication that they used it. 
If those evaluations followed by clearly indication that the method is used, then we classify the 
citation as “methods citation.”  
Taking a Boltzmann average of NMR parameters computed for individual conformers, 
as suggested for example by Willoughby and co?€?workers,<cite data-
doi="10.1038/nprot.2014.042">10</cite> is necessary but unfortunately 
insufficient to model real systems. 
6. What about a citation next to a research material or methods, but without any context to 
support why it is there. (solved) 
7. What to do with included studies? Are they methods keystones? We don’t think they are for 
the moment.
